HIV Flashcards
How can pace of progression to AIDS be predicted?
Viral load after initial infection - a high set point predicts rapid progression
What is the structure of gp160?
gp40 is the stalk through the membrane, gp120 is the globular top
What are the binding receptors for HIV?
Binds CD4, also needs co-receptors CCR5 and/or CXCR4
Describe the initial stages of HIV infection
Get acute infection - R5 virus normally transmits. Get a burst of viral replication and depletion of CD4 T cells in the gut. Flu like symptoms associated with the cytokine response
Describe the asymptomatic phase of HIV infection
Viral infection is contained after initial burst. High viral turnover but is asymptomatic. CD4 cells are activated and slowly decline in number. When thymic function becomes impaired, T cell depletion increases. At the end, T cells are so low that the host is susceptible to tumours and infection
Describe the AIDS stage of HIV infection
Increase in viral replication and collapse of immune system. The host is susceptible to opportunistic infections and tumours. Leads to death. Can take 2-20 years to arise with no drugs
How is a HIV infection established?
Mucosal infection - free virus particles or infected cells move across the mucosal barrier and establish a small foci of infection. Virus spreads locally then to lymphoid tissues (containing CD4 T cells). Infection then spreads systemically to all lymphoid tissues, including gut lymphoid. When the virus starts to deplete CD4 T cells there is large damage to the immune system and a high viral titre so the virus can’t be eradicated.
What factors affect the persisting viral load in an HIV infection?
Viral type - CXCR4 virus is rarely passed on but has a higher pathogenicity. Deletions in virulence genes such as Nef cause lower pathogenicity
Host genetics - deletions in CCR5 promoter region: if homozygous no CCR5 for infection. If heterozygous lower levels of viral replication. Immune response may also be infected e.g. some HLA alleles are associated with good viral control - suggests that control by early immune response is important in determining persisting viral load and therefore disease progression
What is the immune response to an initial HIV infection?
Dendritic cells produce lots of cytokines and chemokine at the local infection site. CD4 cells are recruited by beta chemokine (not good). Inflammatory cytokines active the immune system. HIV is not a stealth infection as needs to infect the immune system.
What is the immune response as HIV spreads systemically?
Get a cytokine storm: type 1 IFNs mediate antiviral activity and act as an adjuvant to other immune responses.
What are the pros and cons of the initial immune response to HIV infection
Type 1 IFNs have direct antiviral activity and act as an adjuvant
Chemokines that attract T cells fuel viral replication. Activation of the immune response by inflammatory cytokines drives viral replication
Pro apoptotic effects of TFNalpha and IFNalpha may contribute to declining T cell numbers
How does interfering with the IFN response affect HIV early infection?
Blocking type 1 IFN receptors at the early stage of HIV infection reduces antiviral gene expression and results in more virus production and faster T cell depletion, leading to AIDS even when block is removed
If type 1 IFN is given immediately before infection, antiviral gene expression is increased and infection is blocked
If type 1 IFN is given for a while before infection, negative feedback turns off antiviral gene expression but the immune system is still activated leading to high viral replication titre.
How do NK cells act in early HIV infection?
Important - up regulating NK receptors and ligands helps control of the virus
NK cells can control HIV replication in vivo
NK cells can lyse HIV specific CD4 cells which is detrimental
How does HIV evade cytokines?
Not in acute infection
Accessory proteins later act to interfere with some ISGs e.g. degradation of APOBEC3G by Vif and sequestering of tetherin by Vpu
Viruses that are transmitted tend to be more resistant to IFN - suggests a bottle neck in selection
How does HIV evade NK cells?
In chronic infection there is altered NK functionality - increased number of inhibitory receptors and decreased numbers of activating receptors
Tat protein may aid resistance to NK cell lysis by blocking calcium influx and inhibiting degranulation
How does HIV interfere with HLA allele expression?
Down regulates HLA-A,B, and C expression which presents HIV peptides to CTLs but not HLA-E which presents peptide from signal sequence of class 1 molecules to inhibit NK cells Does this by 2 exon Tat decreasing activity of MHC class 1 promoter and Nef stimulating endocytosis and degradation of surface HLA-A/B. Vpu induces HLA-C down regulation in a similar way
Describe the profile of antibody expression in an HIV infection
Increase in antibody response as acute infection starts to be controlled. May aid in viral control through ADCC and complement fixation
Neutralising antibodies aren’t produced for a few months
Why does it take so long for neutralising antibody to be expressed in HIV infection?
Not many B cells are specific as many antigens look like ‘self’.
Lack of CD4 T cell help
Cytokine storm drives polyclonal B cell amplification so neutralising B cells are diluted out
Apoptotic microparticles on the surface of B cells?
How is HIV resistant to detection by antibodies?
Does antigenic variation
Envelope protein is trimeric (part of protein hidden at interfaces) with a dense glycan shield that antibodies have to be able to get past
CD4 binding site is protected by variable protein loops
Chemokine receptor binding site is only exposed transiently after binding to CD4
What are the 5 sites that would be ideal for antibody targeting on HIV? What are the problems with this?
CD4 binding site
V1V2V3 loops
Interface between gp41 and gp120
Foot of protein where it attaches to the lipid
Only one of these sites is just protein (CD4 binding), rest are partially sugar/lipid which is similar to host - have to be very specific. Need a lot of somatic hypermutation to form neutralising antibody